Atlas Trials

Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection

Clinical trial NCT00192504 · COMPLETED

Trial details

NCT number
NCT00192504
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Respiratory Syncytial Virus Prophylaxis
Start date
2004-03-01
Primary completion
2005-01-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.